New Resorcinol−Anandamide “Hybrids” as Potent Cannabinoid Receptor Ligands Endowed with Antinociceptive Activity in Vivo
作者:Antonella Brizzi、Vittorio Brizzi、Maria Grazia Cascio、Federico Corelli、Francesca Guida、Alessia Ligresti、Sabatino Maione、Adriano Martinelli、Serena Pasquini、Tiziano Tuccinardi、Vincenzo Di Marzo
DOI:10.1021/jm8016255
日期:2009.4.23
resorcinol−anandamide “hybrids” differing in the side chain group. Compounds bearing a 2-methyloctan-2-yl group at position 5 showed a significantly higher affinity for cannabinoid (CB) receptors, in particular when an alkyloxy chain of 7 or 10 carbon atoms was also present at position 1. Derivative 32 was a potent CB1 and CB2 ligand, with Ki values similar to that of WIN 55-212 and potent antinociceptive
铭记两者的药效要求( - ) -反式-Δ 9四氢大麻酚(THC)和大麻素(AEA),我们设计了新型的药效同时包含一个刚性的芳族主链和柔性链的,目的是开发出了一系列稳定有效的大麻素受体配体。在本文中,我们报告了在侧链组中不同的新间苯二酚-阿南酰胺“杂化物”的合成,对接研究和结构-活性关系。在5位带有2-甲基辛-2-基基团的化合物显示出对大麻素(CB)受体具有显著更高的亲和力,特别是当7个或10个碳原子的烷氧基链也存在在位置1衍生物32是一个有效的CB 1和CB2个配体,其K i值类似于WIN 55-212,并且在体内具有强大的抗伤害感受活性。此外,衍生物38尽管效力较低,但被证明是CB 2受体的最具选择性的配体(K i(CB 1)= 1μM,K i(CB 2)= 35 nM)。